Recursion· @RecursionPharma · X·· 2026-10-12AI 评分28
AI 导读
感谢 @nathanbenaich 和 @airstreet 的年度 State of AI Report。很高兴我们因 REC-4881 的工作被收录,这是一种 MEK1/2 抑制剂,目前正针对 FAP 开展 Phase 2 临床试验。同样被收录的还有 Nesso-1:一个开源模型,可在数秒内预测结合亲和力,加速早期药物发现。
正文 · 原文
Thanks to @nathanbenaich and @airstreet for their annual State of AI Report. We’re happy to be included for our work on REC-4881, a MEK1/2 inhibitor currently in Phase 2 clinical trials for FAP. Also featured is Nesso-1: an open-source model that predicts binding affinity in seconds to unlock faster early-stage drug discovery.
welcome to the 9th annual @stateofai report! ai building better ai, world models, physical ai, geopolitics, cyber defense and 12-month predictions. read it at stateof(dot)ai or watch my editor’s cut here. a few of this year’s biggest findings follow:在 X 查看被引用的帖子
来源:Recursion · x.com